📊 More inclusive definitions of non-acute decompensation #NAD to improve #RiskStratification in chronic #LiverDisease.

✨ POSTER WED-485 by Martin S. McCoy et al. was featured in today's #PosterTour!

#EASLCongress #Cirrhosis

@medblab.bsky.social
@easlnews.bsky.social
@europeliver.bsky.social

✨ #PosterTour today at #EASLCongress 2025:
All our 3 Horizon2020 #LiverResearch projects in 1 session!

Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp

💡 Big moments:

#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)

#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)

👏 What an accomplishment 🥳

Frederike Krus selected for this afternoon's #PosterTour at #EASLCongress

👉 POSTER ID FRI-175

Loss of hepatic #leptin clearance is associated with the development of #ACLF, acute-on-chronic #LiverFailure

📍 #Cirrhosis & Complications
📅 Fri, 9 May

@medblab.bsky.social

🧬Constitutive #MAS1 activation may reduce #LiverFibrosis and #PortalHypertension in chronic liver disease!

🚨See POSTER FRI-329 by Philipp Althaus et al. (last author + #PosterTour presenter today: Sabine Klein, @medblab.bsky.social at UKM)

#EASLCongress #Hepatology #EASL2026

@easlnews.bsky.social

🌎 Regional variation in #Rifaximin use & #GutMicrobiota composition in European patients with decompensated #cirrhosis:

✨ The outstanding international collaboration & poster SAT-467-YI by Susan Fischer et al. was featured during today's afternoon #PosterTour at Track Hub 6!

#EASL2026 #Hepatology

Hello from Day 2 of EULAR Congress!
Don’t miss Poster Tour 4 in 30 minutes – all about Clinical and Treatment Aspects of Spondyloarthritis.

#EULAR2025 #PosterTour #Spondyloarthritis
IH

Big crowd at the #ACLF & Critical Illness #PosterTour at #EASLCongress:

FRI-197
The AMMON-OHE model predicts #liver-related #complications in #outpatients with #cirrhosis: A prospective cohort study of the #AMMON consortium

Crucial for understanding the disease progression!
@rajivjalan.bsky.social

🌟 POSTER THU-182 by Supachaya S. (UCL, @rajivjalan.bsky.social) featured in a #PosterTour at #EASLCongress! 👏

👉 Transcriptomic & metabolic insights into #hyperammonemia: The complementary therapeutic roles of #TLR4 inhibitor (#TAK242) + ornithine phenylacetate

👍 In A-TANGO, we use #TAK242 + G-CSF

#RCNresearch25 #Day2 @rcnresearchforum.bsky.social @rcn.org.uk #Research #Nursing #chairing #postertour looking forward to the day ahead - key note

✨ Poster-Tour Highlight ✨: ACLF #MetabolicMarkers can identify or exclude #BacterialInfections in acutely decompensated #cirrhosis.

#POSTER SAT-329-YI (Frederik Holz et al.) was featured & presented during a morning #PosterTour on Thursday already by Sania Arif - congrats! 🥳

@medblab.bsky.social

🧪 Minneke Coenraad (LUMC) chaired the last #PosterTour today on "Experimental and Pathophysiology" at the Cirrhosis & Complications Track Hub!

💫 Marie Bobowski-Gerard (GENFIT) did a fantastic job presenting this poster, a collaboration with @medblab.bsky.social:

👉 #Poster FRI-383

#EASLCongress

👏 Special honours go to Josune Cabello Calleja for being featured in this afternoon’s #PosterTour on
#Cirrhosis & its complications - #ACLF & Critical illness.

👉 SAT-458-YI
Beneficial impact of consequent non-selective #BetaBlocker intake on patient outcomes in all stages of chronic #LiverDisease

🧪 A deep dive into basic & translational science: Minneke Coenraad (LUMC) chaired today's last #PosterTour on "Experimental and Pathophysiology" at the Cirrhosis & Complications Track Hub!

💫 Meiqian Hu from Rajiv Jalan's group (UCL) did a fantastic job presenting her poster!
#EASLCongress #EASL2026